ClinicalTrials.gg
RecruitingNCT07795294SREP-HNCUpdated Oct 7, 2026

Swallowing Rehabilitation Program for Head and Neck Tumor Patients

An interventional study of Swallowing Rehabilitation Program in Head and Neck Cancer (H&N), sponsored by Delta University for Science and Technology. Recruiting at 1 site in Egypt. Open to participants aged 20 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-10-07.

Sponsored by Delta University for Science and Technology · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Aug 2026; still recruiting 2 months later.
Updated Oct 7, 2026Now RecruitingSite recruiting status changedGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
20 Years to 60 Years
Sex
All
01

Study summary

This study aims to evaluate the effect of a structured swallowing rehabilitation program on swallowing function, trismus severity, and pain among patients with head and neck tumors, using a randomized controlled trial design. Eighty patients will be randomly allocated into two equal groups: a study group receiving the swallowing rehabilitation program and a control group receiving standard care.

Read the detailed description

The swallowing rehabilitation program is a structured intervention designed to improve swallowing ability, mouth opening, and jaw mobility in patients with head and neck tumors. It includes the Mendelsohn maneuver, effortful swallow, Masako technique, tongue strengthening, and jaw range-of-motion and stretching exercises, performed as three sets of ten repetitions twice daily. The program is delivered across four phases (assessment, planning, implementation, and evaluation) over structured orientation, theoretical, and practical sessions. Outcomes are assessed using the EAT-10 (swallowing function) and the Gothenburg Trismus Questionnaire 2 / GTQ2 (trismus severity), in addition to pain level, at baseline and 6 weeks after initiation of the program.

02

Conditions studied

  • Head and Neck Cancer (H&N)

Keywords

  • Dysphagia
  • Trismus
  • Swallowing Rehabilitation
  • Deglutition Disorders
  • Head and Neck Cancer
  • EAT-10
  • Gothenburg Trismus Questionnaire
03

In context

Head and Neck Neoplasms

2,710 studies on the registry are indexed under Head and Neck Neoplasms; 594 are open to participants now.

This study's planned enrollment of 80 is above the median of 46 across 2,032 interventional studies indexed under Head and Neck Neoplasms.

Browse Head and Neck Neoplasms studies →

Lead sponsor

Delta University for Science and Technology is the lead sponsor of 86 studies on the registry; 16 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Both genders
  • Aged 20-60 years
  • Patients receiving chemoradiotherapy
  • Patients having a history of head and neck cancer
  • Patients who had received previous radiation therapy for head and neck cancer

Exclusion criteria

Exclusion Criteria:

  • Patients who had neurological or psychiatric problems
  • Patients who had dysphagia for a reason other than cancer
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    Swallowing Rehabilitation Program

    Participants will receive a structured swallowing rehabilitation program including Mendelsohn maneuver, effortful swallow, Masako technique, tongue strengthening exercises, and jaw range-of-motion and stretching exercises. Exercises will be performed as three sets of ten repetitions, twice daily, delivered across orientation, theoretical, and practical sessions over four phases (assessment, planning, implementation, evaluation).

    Behavioral: Swallowing Rehabilitation Program

  • No intervention
    Standard Care

    Patients receive routine standard care with no structured rehabilitation program.

Interventions

  • BehavioralSwallowing Rehabilitation Program

    A structured program including Mendelsohn maneuver, effortful swallow, Masako technique, tongue strengthening exercises, and jaw range-of-motion and stretching exercises, performed as three sets of ten repetitions twice daily, delivered through orientation, theoretical, and practical sessions.

06

What researchers measure

Primary outcomes

  1. Change in Swallowing Function as Measured by the Eating Assessment Tool-10 (EAT-10)

    Swallowing function assessed using the Eating Assessment Tool-10 (EAT-10), a 10-item self-administered questionnaire with total scores ranging from 0 to 40, with higher scores indicating greater swallowing difficulty (0-3 = normal swallowing, ≥4 = possible dysphagia, 10-20 = moderate dysphagia, \>20 = severe dysphagia).

    Time frame: Baseline and 6 weeks after initiation of the swallowing rehabilitation program

Secondary outcomes

  1. Change in Trismus Severity as Measured by the Gothenburg Trismus Questionnaire 2 (GTQ-2)

    Trismus severity assessed using the Gothenburg Trismus Questionnaire 2 (GTQ-2), a 20-item questionnaire with total scores ranging from 24 to 120, with higher scores indicating greater trismus severity (24 = no trismus, 25-57 = mild, 58-89 = moderate, 90-120 = severe trismus).

    Time frame: Baseline and 6 weeks after initiation of the swallowing rehabilitation program

Other outcomes

  1. Change in Pain Level as Measured by the Numerical Pain Scale (NPS)

    Pain level assessed using the Numerical Pain Scale (NPS), ranging from 0 to 10, with higher scores indicating greater pain severity (0 = none, 1-3 = mild, 4-6 = moderate, 7-10 = severe pain).

    Time frame: Baseline and 6 weeks after initiation of the swallowing rehabilitation program

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Status
Not yet recruiting→Recruiting
changed Oct 7, 2026
Sites
National Cancer Institute, Cairo University is now Recruiting
Oct 7, 2026
Show all 1 update
  1. Oct 7, 2026
    Not yet recruiting→Recruiting
    National Cancer Institute, Cairo University is now Recruiting
    + 1 other change: date precision

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07795294
Lead sponsor
Delta University for Science and Technology
Collaborators
National Cancer Institute, Cairo, Clinical Oncology department. Elmansoura University.
Responsible party
Sponsor
First posted
Aug 31, 2026
Start date
Aug 31, 2026
Primary completion
Dec 25, 2026 (estimated)
Completion
Jun 25, 2027 (estimated)
Last update
Oct 7, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion